- Report
- March 2025
- 92 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 272 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- March 2025
- 200 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- March 2025
- 400 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- January 2025
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- February 2025
- 184 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- May 2024
- 145 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- December 2024
- 144 Pages
Global
From €14255EUR$14,995USD£11,976GBP
- Report
- October 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- October 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- June 2024
- 218 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- July 2024
- 153 Pages
Global
From €4040EUR$4,250USD£3,394GBP

The Smart Insulin market is a subset of the larger Diabetes Devices market. It is composed of products that are designed to help people with diabetes better manage their condition. Smart Insulin products are designed to automatically adjust the amount of insulin delivered to the body based on the user's blood sugar levels. This helps to reduce the risk of hypoglycemia and other complications associated with diabetes. Smart Insulin products are typically connected to a smartphone or other device, allowing users to monitor their blood sugar levels and adjust their insulin dosage accordingly.
The Smart Insulin market is growing rapidly, driven by the increasing prevalence of diabetes and the need for better management of the condition. The market is expected to continue to grow in the coming years, as more people are diagnosed with diabetes and the need for better management of the condition increases.
Some companies in the Smart Insulin market include Bigfoot Biomedical, Beta Bionics, Companion Medical, and Senseonics. Show Less Read more